Sirius Therapeutics Co., Ltd.

This early-stage study is testing a new injectable drug called SRSD216 in people with high levels of lipoprotein(a), a type of fat in the blood linked to heart disease risk. The main goals are to check if the drug is safe and well-tolerated, and to see how it affects lipoprotein(…

This study is testing a new investigational drug, SRSD107, to see if it works better and is as safe as the standard blood thinner (enoxaparin) at preventing dangerous blood clots after knee replacement surgery. It will involve about 450 adults aged 60-80 who are scheduled for thi…